Kawahara M - Search Results

1

Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.

Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, Shiraishi T, Horinouchi H. Kato H, et al. Among authors: kawahara m. Lung Cancer. 2003 Oct;42(1):103-11. doi: 10.1016/s0169-5002(03)00242-3. Lung Cancer. 2003. PMID: 14512194 Clinical Trial.

2

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N; Japan Clinical Oncology Group. Noda K, et al. Among authors: kawahara m. N Engl J Med. 2002 Jan 10;346(2):85-91. doi: 10.1056/NEJMoa003034. N Engl J Med. 2002. PMID: 11784874 Free article. Clinical Trial.

3

A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.

Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M. Atagi S, et al. Among authors: kawahara m. Lung Cancer. 2002 Apr;36(1):105-11. doi: 10.1016/s0169-5002(01)00460-3. Lung Cancer. 2002. PMID: 11891041 Clinical Trial.

4

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N. Takada M, et al. Among authors: kawahara m. J Clin Oncol. 2002 Jul 15;20(14):3054-60. doi: 10.1200/JCO.2002.12.071. J Clin Oncol. 2002. PMID: 12118018 Clinical Trial.

5

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer.

Naka N, Kawahara M, Okishio K, Hosoe S, Ogawara M, Atagi S, Takemoto Y, Ueno K, Kawaguchi T, Tsuchiyama T, Furuse K. Naka N, et al. Among authors: kawahara m. Lung Cancer. 2002 Sep;37(3):319-23. doi: 10.1016/s0169-5002(02)00073-9. Lung Cancer. 2002. PMID: 12234702 Clinical Trial.

6

The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer.

Sawabata N, Keller SM, Matsumura A, Kawashima O, Hirono T, Osaka Y, Maeda H, Fukai S, Kawahara M; Japan National Chest Hospital Study Group for Lung Cancer. Sawabata N, et al. Among authors: kawahara m. Lung Cancer. 2003 Oct;42(1):69-77. doi: 10.1016/s0169-5002(03)00245-9. Lung Cancer. 2003. PMID: 14512190

7

A phase II study of topotecan in patients with relapsed small-cell lung cancer.

Takeda K, Negoro S, Sawa T, Nakagawa K, Kawahara M, Isobe T, Kudoh S, Masuda N, Niitani H, Fukuoka M. Takeda K, et al. Among authors: kawahara m. Clin Lung Cancer. 2003 Jan;4(4):224-8. doi: 10.3816/clc.2003.n.002. Clin Lung Cancer. 2003. PMID: 14624710

8

Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group.

Kubota K, Watanabe K, Kunitoh H, Noda K, Ichinose Y, Katakami N, Sugiura T, Kawahara M, Yokoyama A, Yokota S, Yoneda S, Matsui K, Kudo S, Shibuya M, Isobe T, Segawa Y, Nishiwaki Y, Ohashi Y, Niitani H; Japanese Taxotere Lung Cancer Study Group. Kubota K, et al. Among authors: kawahara m. J Clin Oncol. 2004 Jan 15;22(2):254-61. doi: 10.1200/JCO.2004.06.114. J Clin Oncol. 2004. PMID: 14722033 Clinical Trial.

9

Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer--a multicenter study.

Kawai H, Tada A, Kawahara M, Nakai K, Maeda H, Saitou R, Iwami F, Ishikawa K, Fukai S, Komatsu H; Japan National Hospital Study Group for Lung Cancer. Kawai H, et al. Among authors: kawahara m. Lung Cancer. 2005 Jul;49(1):63-70. doi: 10.1016/j.lungcan.2004.12.006. Epub 2005 Feb 17. Lung Cancer. 2005. PMID: 15949591

10

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.

Endo K, Konishi A, Sasaki H, Takada M, Tanaka H, Okumura M, Kawahara M, Sugiura H, Kuwabara Y, Fukai I, Matsumura A, Yano M, Kobayashi Y, Mizuno K, Haneda H, Suzuki E, Iuchi K, Fujii Y. Endo K, et al. Among authors: kawahara m. Lung Cancer. 2005 Dec;50(3):375-84. doi: 10.1016/j.lungcan.2005.08.009. Epub 2005 Sep 30. Lung Cancer. 2005. PMID: 16199108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

896 results

Search Page